William J. Valentine

Author

Also Known As

Hansen, L.L., Pollock, R.F., Richard F. Pollock, W Valentine, W. J. VALENTINE, W. J. Valentine, W. Valentine, W.J. Valentine, WILLIAM J. VALENTINE, WJ Valentine

189

Publications

4.6K

Citations

H-Index

Concepts

All Affiliations

Novo Nordisk (Denmark)Novo Nordisk (United States)Eli Lilly (United States)Novo Nordisk (United Kingdom)Medtronic (Switzerland)

About

William J. Valentine is an author at Novo Nordisk (Denmark) specializing in diabetes, medicine, and health economics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	16	467
2	Public Health	8	8	441
3	Health Sciences	2	2	140
4	Engineering	1	1	75
5	Biostatistics	1	1	75

William J. Valentine

Publications

3.2K

Citations

H-Index

Page 1

	Year	Citations
The CORE Diabetes Model: Projecting Long-term Clinical Outcomes, Costs and Costeffectiveness of Interventions in Diabetes Mellitus (Types 1 and 2) to Support Clinical and Reimbursement Decision-making Andrew Palmer, Stéphane Roze, William J. Valentine, Current Medical Research and Opinion	2004	519
Cost-Effectiveness of Intensified Versus Conventional Multifactorial Intervention in Type 2 Diabetes Peter Gæde, William J. Valentine, Andrew Palmer, Diabetes Care	2008	144
Intensive lifestyle changes or metformin in patients with impaired glucose tolerance: Modeling the long-term health economic implications of the diabetes prevention program in Australia, France, Germany, Switzerland, and the United Kingdom Andrew Palmer, Stéphane Roze, William J. Valentine, Clinical Therapeutics ObesityMetabolic SyndromeDiabetes ManagementLifestyle ModificationHealth Economics	2004	127
Health‐economic comparison of continuous subcutaneous insulin infusion with multiple daily injection for the treatment of Type 1 diabetes in the UK S Roze, William J. Valentine, Katerina Zakrzewska, Diabetic Medicine	2005	95
Evaluating the clinical and economic burden of healthcare-associated infections during hospitalization for surgery in France Ludovic Lamarsalle, Bijou R. Hunt, M. SCHAUF, Epidemiology and Infection Surgical ProceduresSurgerySurgical Site InfectionsPreventive MedicineHealthcare-associated Infection	2013	89
<p>Impact of Stigma on People Living with Chronic Hepatitis B</p> Jayne Smith‐Palmer, Karin Cerri, U. Sbarigia, Patient Related Outcome Measures	2020	88
Cost‐Effectiveness of Diabetes Case Management for Low‐Income Populations Todd Gilmer, Stéphane Roze, William J. Valentine, Health Services Research	2007	79
Computer Modeling of Diabetes and Its Transparency: A Report on the Eighth Mount Hood Challenge Andrew Palmer, Lei Si, Michelle Tew, Value in Health ObesityDiabetes ManagementEngineeringInsulin ManagementDiabetes	2018	75
The consequences of delaying insulin initiation in UK type 2 diabetes patients failing oral hyperglycaemic agents: a modelling study G Goodall, Eric Sarpong, Clarice Hayes, BMC Endocrine Disorders	2009	63
Smart Insulin Pens are Associated with Improved Clinical Outcomes at Lower Cost Versus Standard-of-Care Treatment of Type 1 Diabetes in Sweden: A Cost-Effectiveness Analysis Johan Jendle, Åsa Ericsson, Jens Gundgaard, Diabetes Therapy	2020	62

Page 1